The degree of left atrial structural remodeling impacts left ventricular ejection fraction in patients with atrial fibrillation

Turk Kardiyoloji Dernegi Arsivi

Volumn 42, Issue 1, 2014, Pages 11-19

  Akkaya, Mehmet ^a   Marrouche, Nassir ^a   Higuchi, Koji ^a   Koopmann, Matthias ^a   Damal, Kavitha ^a   Kholmovski, Eugene ^a   McGann, Chris ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Atrial fibrillation drug therapy; Catheter ablation; Heart atria; Imaging, three dimensional; Magnetic resonance imaging; Myocardium

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPH; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HEART ATRIUM SEPTUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; RETROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY; UNITED STATES; ATRIAL FIBRILLATION; HEART ATRIUM FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; ATRIAL REMODELING; FEMALE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME;

EID: 84900396449     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2014.20726     Document Type: Article

References (35)

1. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-3. CrossRef
2. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46. CrossRef (Pubitemid 34327903)
3. Boixel C, Fontaine V, Rücker-Martin C, Milliez P, Louedec L, Michel JB, et al. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metallo-proteinases in the rat. J Am Coll Cardiol 2003;42:336-44. (Pubitemid 36851427)
4. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011;22:16-22. CrossRef
5. Frustaci A, Caldarulo M, Buffon A, Bellocci F, Fenici R, Melina D. Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest 1991;100:303-6. CrossRef
6. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4. CrossRef (Pubitemid 27344221)
7. Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004;90:400-5. CrossRef (Pubitemid 38406914)
8. Steinberg JS. Atrial fibrillation: an emerging epidemic? Heart 2004;90:239-40. CrossRef (Pubitemid 38250702)
9. Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J 2001;22:623-6. CrossRef (Pubitemid 32622421)
10. Wasmund SL, Li JM, Page RL, Joglar JA, Kowal RC, Smith ML, et al. Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation 2003;107:2011-5. CrossRef (Pubitemid 36506075)
11. Nattel S, Li D. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 2000;87:440-7. CrossRef
12. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-15. CrossRef (Pubitemid 27128241)
13. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119:1758-67. CrossRef
14. McGann CJ, Kholmovski EG, Oakes RS, Blauer JJ, Daccarett M, Segerson N, et al. New magnetic resonance imagingbased method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 2008;52:1263-71. CrossRef
15. Akoum N, McGann C, Vergara G, Badger T, Ranjan R, Mahnkopf C, et al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol 2012;23:44-50. CrossRef
16. Marrouche NF, Natale A, Wazni OM, Cheng J, Yang Y, Pollack H, et al. Left septal atrial flutter: electrophysiology, anatomy, and results of ablation. Circulation 2004;109:2440-7. (Pubitemid 38679565)
17. Ausma J, Wijffels M, Thoné F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-63. CrossRef (Pubitemid 27500121)
18. Pujadas S, Vidal-Perez R, Hidalgo A, Leta R, Carreras F, Barros A, et al. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. Eur J Radiol 2010;75:88-91. CrossRef
19. Burstein B, Libby E, Calderone A, Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 2008;117:1630-41. CrossRef (Pubitemid 351482606)
20. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A, et al. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 2003;284:H1313-20. (Pubitemid 36348595)
21. Edner M, Caidahl K, Bergfeldt L, Darpö B, Edvardsson N, Rosenqvist M. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995;74:261-7.
22. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000;75:790-5. CrossRef (Pubitemid 30640636)
23. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 1996;19:95-106. CrossRef (Pubitemid 26033209)
24. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003;91:2D-8D. CrossRef (Pubitemid 36369329)
25. Everett TH 4th, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007;4:24-7. CrossRef
26. Clemo HF, Stambler BS, Baumgarten CM. Swelling-activated chloride current is persistently activated in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res 1999;84:157-65. CrossRef (Pubitemid 29070111)
27. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 2003;108:1461-8. CrossRef (Pubitemid 37176452)
28. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function Circ Res 1998;82:482-95. CrossRef (Pubitemid 28117330)
29. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9. CrossRef (Pubitemid 351260071)
30. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, et al. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm 2004;1:669-75. CrossRef (Pubitemid 40028772)
31. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-9. (Pubitemid 40789940)
32. Heyer CM, Kagel T, Lemburg SP, Bauer TT, Nicolas V. Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest 2003;124:2068-73. CrossRef (Pubitemid 38010570)
33. Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Adipose tissue of atrial septum as a marker of coronary artery disease. Chest 2007;132:817-22. CrossRef
34. López-Candales A, Grewal H, Katz W. The importance of increased interatrial septal thickness in patients with atrial fibrillation: a transesophageal echocardiographic study. Echocardiography 2005;22:408-14. CrossRef (Pubitemid 40677180)
35. Dinsmore RE, Wismer GL, Guyer D, Thompson R, Liu P, Stratemeier E, et al. Magnetic resonance imaging of the inter-atrial septum and atrial septal defects. AJR Am J Roentgenol 1985;145:697-703. CrossRef (Pubitemid 16216498)